{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:41:23Z","timestamp":1792244483982,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K15384"],"award-info":[{"award-number":["21K15384"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10107"],"award-info":[{"award-number":["24K10107"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K12930"],"award-info":[{"award-number":["25K12930"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.labinv.2026.106168","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:17:09Z","timestamp":1790137029000},"page":"106168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Molecular and Clinicopathological Profiling of Lymphatic Malformations"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4148-1106","authenticated-orcid":false,"given":"Katsutoshi","family":"Hirose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2306-345X","authenticated-orcid":false,"given":"Yumiko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Motooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Toyosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2026.106168_bib2","series-title":"WHO Classification of Tumours. Paediatric Tumours","first-page":"477","year":"2023"},{"key":"10.1016\/j.labinv.2026.106168_bib3","series-title":"Vascular Anomalies: A Guide for the Hematologist\/Oncologist","first-page":"145","author":"Trenor","year":"2020"},{"key":"10.1016\/j.labinv.2026.106168_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.121.318142","article-title":"Lymphatic malformations: genetics, mechanisms and therapeutic strategies","volume":"129","author":"M\u00e4kinen","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.labinv.2026.106168_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172844","article-title":"Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers","volume":"134","author":"Petkova","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.labinv.2026.106168_bib6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.labinv.2026.106168_bib7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jamadermatol.2021.3459","article-title":"Sirolimus (rapamycin) for slow-flow malformations in children: the observational-phase randomized clinical PERFORMUS trial","volume":"157","author":"Maruani","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.labinv.2026.106168_bib8","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1007\/s00405-022-07378-8","article-title":"Efficacy of sirolimus in children with lymphatic malformations of the head and neck","volume":"279","author":"Wiegand","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.labinv.2026.106168_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/cts.13488","article-title":"Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations\u2014a nationwide trial","volume":"16","author":"Harbers","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.labinv.2026.106168_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173095","article-title":"Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations","volume":"8","author":"Seront","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.labinv.2026.106168_bib11","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/lary.31091","article-title":"Sirolimus for pediatric cervicofacial lymphatic malformation: a systematic review and meta-analysis","volume":"134","author":"Kamhieh","year":"2024","journal-title":"Laryngoscope"},{"key":"10.1016\/j.labinv.2026.106168_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1084\/jem.20181353","article-title":"Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly","volume":"216","author":"Rodriguez-Laguna","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.labinv.2026.106168_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.labinv.2026.106168_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200343","article-title":"PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations","volume":"13","author":"Blesinger","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.labinv.2026.106168_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129884","article-title":"Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations","volume":"4","author":"Zenner","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.labinv.2026.106168_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13023-021-01898-y","article-title":"Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations","volume":"16","author":"Brouillard","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.labinv.2026.106168_bib17","first-page":"1460","article-title":"Analysis of the occurrence of PIK3CA gene mutation in children with lymphatic malformation\u2014single center study","volume":"12","author":"Kukulska","year":"2025","journal-title":"Children (Basel)"},{"key":"10.1016\/j.labinv.2026.106168_bib18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molmed.2018.08.003","article-title":"Cancer-associated PIK3CA mutations in overgrowth disorders","volume":"24","author":"Madsen","year":"2018","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.labinv.2026.106168_bib19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s44161-022-00107-8","article-title":"When, where and which PIK3CA mutations are pathogenic in congenital disorders","volume":"1","author":"Angulo-Urarte","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.labinv.2026.106168_bib20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/hmg\/ddu505","article-title":"Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations","volume":"24","author":"Osborn","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.labinv.2026.106168_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10456-014-9453-2","article-title":"AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation","volume":"18","author":"Boscolo","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.labinv.2026.106168_bib22","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/s41467-020-16496-y","article-title":"Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation","volume":"11","author":"Martinez-Corral","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.labinv.2026.106168_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2350\/08-05-0471.1","article-title":"Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations\u2014a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations","volume":"12","author":"Castro","year":"2009","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.labinv.2026.106168_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155478","article-title":"Lymphangiogenesis requires Ang2\/Tie\/PI3K signaling for VEGFR3 cell-surface expression","volume":"132","author":"Korhonen","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.labinv.2026.106168_bib25","first-page":"1289","article-title":"Embryological cellular origins and hypoxia-mediated mechanisms in PIK3CA-driven refractory vascular malformations","volume":"17","author":"Torii","year":"2025","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.labinv.2026.106168_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000503604","article-title":"Immunohistochemical analysis of mTOR pathway-related proteins in kaposiform hemangioendothelioma","volume":"236","author":"Wang","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.labinv.2026.106168_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/pin.12913","article-title":"Analysis of mTOR pathway expression in lymphatic malformation and related diseases","volume":"70","author":"Hori","year":"2020","journal-title":"Pathol Int"},{"key":"10.1016\/j.labinv.2026.106168_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/diagnostics14010038","article-title":"mTOR pathway substrates present high activation in vascular malformations and significantly decrease with age","volume":"14","author":"Kope\u0107","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.labinv.2026.106168_bib29","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00428-025-04158-7","article-title":"Pathogenic mechanism of extracranial arteriovenous malformations: insights from clinical, pathological, and genetic analyses","volume":"488","author":"Hirose","year":"2026","journal-title":"Virchows Arch"},{"key":"10.1016\/j.labinv.2026.106168_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.job.2026.100779","article-title":"Elucidating disease pathogenesis using formalin-fixed paraffin-embedded samples: integrating genomics, spatial transcriptomics, and histology\u2014a focus on vascular anomalies","volume":"68","author":"Hirose","year":"2026","journal-title":"J Oral Biosci"},{"key":"10.1016\/j.labinv.2026.106168_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.labinv.2026.106168_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.humpath.2024.02.004","article-title":"Comprehensive phenotypic and genomic characterization of venous malformations","volume":"145","author":"Hirose","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.labinv.2026.106168_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/lrb.2017.0064","article-title":"Gene expression differences in pediatric lymphatic malformations: size really matters","volume":"16","author":"Gomez-Acevedo","year":"2018","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.labinv.2026.106168_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/modpathol.3880033","article-title":"Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi\u2019s sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas","volume":"13","author":"Folpe","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2026.106168_bib35","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/labinvest.3780386","article-title":"Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma","volume":"81","author":"Huang","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.labinv.2026.106168_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mod.2009.02.003","article-title":"NFATc1 regulates lymphatic endothelial development","volume":"126","author":"Kulkarni","year":"2009","journal-title":"Mech Dev"},{"key":"10.1016\/j.labinv.2026.106168_bib37","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1182\/blood-2013-12-297317","article-title":"Pressing the right buttons: signaling in lymphangiogenesis","volume":"123","author":"Coso","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.labinv.2026.106168_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.celrep.2013.07.021","article-title":"The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases","volume":"4","author":"Minami","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.labinv.2026.106168_bib39","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1172\/JCI19188","article-title":"Differential regulation of CCL21 in lymphoid\/nonlymphoid tissues for effectively attracting T cells to peripheral tissues","volume":"112","author":"Lo","year":"2003","journal-title":"J Clin Invest"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372600098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372600098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:52:38Z","timestamp":1792241558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002368372600098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S002368372600098X"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106168","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Molecular and Clinicopathological Profiling of Lymphatic Malformations","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"106168"}}